Compounds > 1-amino-1,3-dicarboxycyclopentane

1-amino-1,3-dicarboxycyclopentane and Substance Withdrawal Syndrome

1-amino-1,3-dicarboxycyclopentane has been researched along with Substance Withdrawal Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mortensen, M; Suzdak, PD; Thomsen, C1
Caguioa-Aquino, JN; Gruol, DL; Netzeband, JG; Schneeloch, JR; Trotter, C1

Other Studies

2 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and Substance Withdrawal Syndrome

ArticleYear
The effect of lorazepam tolerance and withdrawal on metabotropic glutamate receptor function.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:1

    Topics: Animals; Cerebral Cortex; Cyclic AMP; Cycloleucine; Drug Tolerance; Hydrolysis; In Vitro Techniques; Lorazepam; Male; Mice; Phosphatidylinositols; Protein Kinases; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Seizures; Substance Withdrawal Syndrome

1995
Chronic ethanol treatment and withdrawal alter ACPD-evoked calcium signals in developing Purkinje neurons.
    Alcoholism, clinical and experimental research, 2002, Volume: 26, Issue:3

    Topics: Action Potentials; Animals; Calcium Signaling; Cell Differentiation; Cells, Cultured; Central Nervous System Depressants; Cerebellum; Cycloleucine; Embryo, Mammalian; Ethanol; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome

2002